Combination Treatment for Severe Forms of Mucopolysaccharidosis, Type I (Hurler Syndrome): Case Report
Background. Hurler syndrome (mucopolysaccharidosis, type I) is a rare hereditary disease with chronic course. The main methods for Hurler syndrome management are hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT). In recent years, combination treatment (ERT administr...
Saved in:
Main Authors: | Nato V. Vashakmadze (Author), Natalia V. Zhurkova (Author), Marina A. Babaykina (Author), Albina V. Dobrotok (Author), Olga B. Gordeeva (Author), Leyla S. Namazova-Baranova (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-Neuropathic Form of Mucopolysaccharidosis Type II: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2021) -
Mucopolysaccharidosis Type I (Hurler - Scheie Syndrome): Case Report
by: Nato D. Vashakmadze, et al.
Published: (2024) -
Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2020) -
Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2019) -
Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020)